for the Period Ended 31 March 2023
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
As at
Notes | 2023 | 2022 | |
---|---|---|---|
| £ | £ | |
Fixed assets | |||
Tangible assets: | 3 | | |
Total fixed assets: | | | |
Current assets | |||
Cash at bank and in hand: | | | |
Total current assets: | | | |
Creditors: amounts falling due within one year: | 4 | ( | ( |
Net current assets (liabilities): | | | |
Total assets less current liabilities: | | | |
Total net assets (liabilities): | | | |
Members' funds | |||
Profit and loss account: | | | |
Total members' funds: | | |
The notes form part of these financial statements
The directors have chosen not to file a copy of the company's profit and loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 March 2023
Basis of measurement and preparation
Turnover policy
Tangible fixed assets depreciation policy
for the Period Ended 31 March 2023
2023 | 2022 | |
---|---|---|
Average number of employees during the period | | |
for the Period Ended 31 March 2023
Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total | |
---|---|---|---|---|---|---|
Cost | £ | £ | £ | £ | £ | £ |
At 1 April 2022 | | | ||||
Additions | | | ||||
Disposals | ||||||
Revaluations | ||||||
Transfers | ||||||
At 31 March 2023 | | | ||||
Depreciation | ||||||
At 1 April 2022 | | | ||||
Charge for year | | | ||||
On disposals | ||||||
Other adjustments | ||||||
At 31 March 2023 | | | ||||
Net book value | ||||||
At 31 March 2023 | | | ||||
At 31 March 2022 | | |
for the Period Ended 31 March 2023
2023 | 2022 | |
---|---|---|
£ | £ | |
Taxation and social security | | |
Other creditors | | |
Total | | |
The activities of the CIC includes seeing patients (including drug treatment and therapy sessions), provide education for patients & their family members through the CIC website and training of health professionals.
The company’s stakeholders are its psychiatric patients and the general population. The stakeholders have been consulted by face to face appointments as well as telephone and video call appointments.
Directors’ remuneration amounted to £29,697 for the year ended 31 March 2023. The directors’ remuneration is for actual consultancy services in seeing patients.There were no other transactions or arrangements in connection with the remuneration of directors, or compensation for director’s loss of office, which require to be disclosed.
No transfer of assets other than for full consideration
This report was approved by the board of directors on
30 October 2023
And signed on behalf of the board by:
Name: Dr Kishore Chandiramani
Status: Director